Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4968 participants

Study Classification

OBSERVATIONAL

Study Start Date

2001-10-31

Study Completion Date

2008-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to systematically collect and document use patterns, effectiveness, and safety of DMARD treatments currently used in the management of rheumatoid arthritis (RA). It is anticipated that study data may help improve the quality of information upon which clinical decisions are based.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis

NCT01225393

Rheumatoid Arthritis

COMPLETED PHASE2

A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)

NCT06276998

Rheumatoid Arthritis

ACTIVE_NOT_RECRUITING PHASE3

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

NCT01636817

Inflammation Rheumatoid Arthritis

TERMINATED PHASE2

A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

NCT06754462

Rheumatoid Arthritis

ACTIVE_NOT_RECRUITING PHASE2

Impact Of RA Therapy Compliance On Patient-Reported Outcomes

NCT01438892

Rheumatoid Arthritis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observation

DMARD

Intervention Type DRUG

All subjects were required to initiate, add or change DMARD therapy at study entry.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DMARD

All subjects were required to initiate, add or change DMARD therapy at study entry.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Fulfillment of the 1987 American Rheumatism Association criteria for RA
* Currently requiring a new DMARD (change or addition)

Exclusion Criteria

* Currently enrolled in a clinical trial with treatments or patient visits imposed by a protocol
* Nursing or pregnant women
* Patients with active infection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No